Expert consensus on the management of B-cell lymphoma-related cardiovascular diseases with Bruton tyrosine kinase inhibitors (2023).
10.3760/cma.j.issn.0253-2727.2023.05.002
- Collective Name:Hematological Oncology Committee of China Anti-Cancer Association;Chinese Society of Hematology, Chinese Medical Association;Chinese Workshop on Chronic Lymphocytic Leukemia
- Publication Type:Journal Article
- MeSH:
Humans;
Cardiovascular Diseases/drug therapy*;
Consensus;
Lymphoma, B-Cell;
Lymphoma, Mantle-Cell;
Tyrosine Protein Kinase Inhibitors/therapeutic use*
- From:
Chinese Journal of Hematology
2023;44(5):359-365
- CountryChina
- Language:Chinese
